Shuttle Pharmaceuticals Prices $4.5 Million Public Offering

MT Newswires Live10-30

Shuttle Pharmaceuticals (SHPH) said late Tuesday it has priced its public offering of up to about 3 million shares and warrants to purchase an additional 3 million shares at a combined price of $1.525 per share and accompanying warrant.

Gross proceeds from the offering are estimated to be about $4.5 million.

The warrants will have an exercise price of $1.40 per share, are immediately exercisable and expire five years after issuance.

Proceeds from the offering, which are expected to close around Thursday, will be used to fund trials of its product candidates, including $2.3 million owed to Theradex Systems for support in phase 2 trials of radiation sensitizer Ropidoxuridine, as well as for general corporate purposes.

Price: 1.7300, Change: -0.07, Percent Change: -3.89

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2479229711?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-30 16:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2479229711","market":"fut","top_or_hot":-1,"title":"Shuttle Pharmaceuticals Prices $4.5 Million Public Offering","media":"MT Newswires Live","content":"<html><body><p> Shuttle Pharmaceuticals (SHPH) said late Tuesday it has priced its public offering of up to about 3 million shares and warrants to purchase an additional 3 million shares at a combined price of $1.525 per share and accompanying warrant.</p><p>Gross proceeds from the offering are estimated to be about $4.5 million.</p><p>The warrants will have an exercise price of $1.40 per share, are immediately exercisable and expire five years after issuance.</p><p>Proceeds from the offering, which are expected to close around Thursday, will be used to fund trials of its product candidates, including $2.3 million owed to Theradex Systems for support in phase 2 trials of radiation sensitizer Ropidoxuridine, as well as for general corporate purposes.</p><p>Price: 1.7300, Change: -0.07, Percent Change: -3.89</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shuttle Pharmaceuticals Prices $4.5 Million Public Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShuttle Pharmaceuticals Prices $4.5 Million Public Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-30 16:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shuttle Pharmaceuticals (SHPH) said late Tuesday it has priced its public offering of up to about 3 million shares and warrants to purchase an additional 3 million shares at a combined price of $1.525...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SHPH","symbol_name":"Shuttle Pharmaceuticals Inc","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2479229711","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2479229711","pubTimestamp":1730276478,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shuttle Pharmaceuticals  said late Tuesday it has priced its public offering of up to about 3 million shares and warrants to purchase an additional 3 million shares at a combined price of $1.525 per share and accompanying warrant.Gross proceeds from the offering are estimated to be about $4.5 million.The warrants will have an exercise price of $1.40 per share, are immediately exercisable and expire five years after issuance.Proceeds from the offering, which are expected to close around Thursday, will be used to fund trials of its product candidates, including $2.3 million owed to Theradex Systems for support in phase 2 trials of radiation sensitizer Ropidoxuridine, as well as for general corporate purposes.Price: 1.7300, Change: -0.07, Percent Change: -3.89","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SHPH":"Shuttle Pharmaceuticals Inc","BK4139":"生物科技"},"translate_title":"Shuttle Pharmaceuticals公开发行定价为450万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SHPH":0.9},"content_text":"Shuttle Pharmaceuticals (SHPH) said late Tuesday it has priced its public offering of up to about 3 million shares and warrants to purchase an additional 3 million shares at a combined price of $1.525 per share and accompanying warrant.Gross proceeds from the offering are estimated to be about $4.5 million.The warrants will have an exercise price of $1.40 per share, are immediately exercisable and expire five years after issuance.Proceeds from the offering, which are expected to close around Thursday, will be used to fund trials of its product candidates, including $2.3 million owed to Theradex Systems for support in phase 2 trials of radiation sensitizer Ropidoxuridine, as well as for general corporate purposes.Price: 1.7300, Change: -0.07, Percent Change: -3.89","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2479229711"}